When should ezetimibe be avoided?

When should ezetimibe be avoided in patients with active liver disease

Ezetimibe is metabolized in the liver, so patients with active liver disease or unexplained persistent elevations in liver transaminases should avoid it. The prescribing information recommends checking liver function tests before starting therapy and monitoring them during use.

How does ezetimibe work when combined with statins

Ezetimibe reduces cholesterol absorption in the small intestine. When added to a statin, it gives an additional 15–25% reduction in LDL cholesterol beyond what the statin alone achieves. This combination is often used when a patient reaches a maximum tolerated statin dose.

What happens if ezetimibe is used with cyclosporine

Cyclosporine raises ezetimibe blood levels about 3- to 4-fold. The manufacturer recommends caution and frequent monitoring of ezetimibe levels and side effects when these two agents are used together.

When does the ezetimibe patent expire

The U.S. patent for ezetimibe expired in 2017. Generic versions are now widely available. [1]

Who makes ezetimibe

Ezetimibe is manufactured by Merck under the brand name Zetia. Generics are produced by multiple companies after the 2017 patent expiry.

What side effects are patients asking about

Patients frequently report muscle pain, fatigue, and elevated liver enzymes. In clinical trials, rates of these complaints were similar between ezetimibe monotherapy and placebo.